Jacques Theurillat
Chairman bij Vifor Pharma Management AG
Vermogen: 597 717 $ op 29-02-2024
Profiel
Jacques Theurillat is een Zwitsers zakenman die EOS SpA heeft opgericht en aan het roer heeft gestaan van 7 verschillende ondernemingen. De heer Theurillat is voorzitter bij Vifor Pharma AG, voorzitter voor Vifor Pharma Management AG (een dochteronderneming van Vifor Pharma AG) en partner bij Sofinnova Partners SAS. Jacques Theurillat is ook lid van de raad van bestuur van Mundipharma, Inc., Napp Pharmaceutical Holdings Ltd., ADC Therapeutics SA en CNH Industrial NV en Partner bij Sofinnova Crossover Fund. In zijn vorige carrière was hij Voorzitter & Chief Executive Officer bij Albea Pharmaceuticals AG, Voorzitter & Chief Executive Officer bij AlbeaPharma AG, Managing Director bij Istituto Farmacologico Serono, Vice-Voorzitter bij Esaote SpA, Chief Executive Officer bij Campus Holding SA, Managing Partner bij Campus Holding SA en CFO & Deputy Chief Executive Officer bij Serono SA. Jacques Theurillat behaalde een diploma aan de Universiteit van Genève, een diploma aan de Universiteit van Madrid en een MBA aan het Centro de Estudios Financieros.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ADC THERAPEUTICS LTD
0.15% | 01-02-2023 | 123 751 ( 0.15% ) | 597 717 $ | 29-02-2024 |
Actieve functies van Jacques Theurillat
Bedrijven | Functie | Begin |
---|---|---|
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 02-02-2016 |
Mundipharma, Inc.
Mundipharma, Inc. Pharmaceuticals: MajorHealth Technology Mundipharma, Inc. manufactures and markets pharmaceutical products. The company is located in Albany, NY. | Director/Board Member | - |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 01-01-2017 |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Chairman | - |
Sofinnova Crossover Fund
Sofinnova Crossover Fund Financial ConglomeratesFinance Sofinnova Crossover Fund provides investment services. | Corporate Officer/Principal | 01-01-2016 |
Eerdere bekende functies van Jacques Theurillat
Bedrijven | Functie | Einde |
---|---|---|
ADC THERAPEUTICS SA | Director/Board Member | 14-06-2023 |
CNH INDUSTRIAL N.V. | Director/Board Member | 15-04-2021 |
Campus Holding SA
Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Director of Finance/CFO | 01-08-2015 |
Campus Holding SA
Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Chief Executive Officer | 01-08-2015 |
░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jacques Theurillat
University of Geneva | Graduate Degree |
Centro de Estudios Financieros | Masters Business Admin |
Madrid University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
CNH INDUSTRIAL N.V. | Producer Manufacturing |
Bedrijven in privébezit | 17 |
---|---|
CNH Global NV
CNH Global NV Trucks/Construction/Farm MachineryProducer Manufacturing CNH Global NV is engaged in the manufacture, engineering, marketing and distribution of agricultural and construction equipment. Its brands include Case, New Holland, Case IH, and New Holland Construction. It operates through the following segments: Agricultural Equipment, Construction Equipment, and Financial Services. The Agricultural Equipment segment manufactures and distributes agricultural machineries such as two-wheel and four-wheel drive tractors, combines, cotton pickers, harvesters, hay tools, planting and seeding equipment, sprayer, and tillage equipment. The Construction Equipment segment offers excavators, crawler dozers, graders, wheel loaders, backhoe loaders, skid steer loaders, and trenchers. The Financial Services segment provides retail and wholesale financing and financing options. The company was founded on August 30, 1996 and is headquartered in Amsterdam, Netherlands. | Producer Manufacturing |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Esaote SpA
Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Health Technology |
Vifor Pharma AG
Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Affidea Group BV
Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Istituto Farmacologico Serono
Istituto Farmacologico Serono Pharmaceuticals: MajorHealth Technology Istituto Farmacologico Serono is an Italian pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Rome, Italy. | Health Technology |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy. | Health Technology |
Albea Pharmaceuticals AG
Albea Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Albea Pharmaceuticals AG specializes in the development and marketing of pharmaceutical products. The company was founded by Werner Tschollar and is headquartered in Zug, Switzerland. | Health Technology |
Campus Holding SA
Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Finance |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Mundipharma, Inc.
Mundipharma, Inc. Pharmaceuticals: MajorHealth Technology Mundipharma, Inc. manufactures and markets pharmaceutical products. The company is located in Albany, NY. | Health Technology |
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Indukern SA
Indukern SA Pharmaceuticals: MajorHealth Technology Indukern SA distributes pharmaceutical and chemical products. It offers ingredients for nutrition, food ingredients, flavors, fragrances, and industrial chemicals. The company was founded by José Luis Díaz-Varela in 1962 and is headquartered in El Prat de Llobregat, Spain. | Health Technology |
AlbeaPharma AG | |
Sofinnova Crossover Fund
Sofinnova Crossover Fund Financial ConglomeratesFinance Sofinnova Crossover Fund provides investment services. | Finance |